We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-2.66%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$344M
AUM Growth
-$21.8M
Cap. Flow
-$6.55M
Cap. Flow %
-1.9%
Top 10 Hldgs %
27.91%
Holding
117
New
5
Increased
25
Reduced
42
Closed
6

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$2.3M
2
PEP icon
PepsiCo
PEP
+$1.5M
3
PG icon
Procter & Gamble
PG
+$1.48M
4
MSFT icon
Microsoft
MSFT
+$993K
5
AAPL icon
Apple
AAPL
+$591K

Sector Composition

Rank Sector Weight
1 Healthcare 14.56%
2 Technology 13.45%
3 Industrials 11.72%
4 Consumer Staples 10.18%
5 Consumer Discretionary 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
51
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$2.82M 0.82%
12,380
IJH icon
52
iShares Core S&P Mid-Cap ETF
IJH
$126B
$2.57M 0.75%
47,975
+800
+2% +$42.6K
VB icon
53
Vanguard Morningstar Small-Cap ETF
VB
$81.8B
$2.38M 0.69%
11,192
-520
-4% -$109K
WU icon
54
Western Union
WU
$2.3B
$2.36M 0.68%
125,814
-9,659
-7% -$179K
USB icon
55
US Bancorp
USB
$100B
$2.35M 0.68%
44,291
-1,250
-3% -$71.8K
CTAS icon
56
Cintas
CTAS
$80B
$2.35M 0.68%
22,120
HYD icon
57
VanEck High Yield Muni ETF
HYD
$4.43B
$2.17M 0.63%
37,796
+320
+0.9% +$19.1K
HYG icon
58
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.08M 0.6%
25,220
-1,847
-7% -$154K
BBH icon
59
VanEck Biotech ETF
BBH
$410M
$2.02M 0.59%
12,481
-864
-6% -$140K
IAU icon
60
iShares Gold Trust
IAU
$66.2B
$1.98M 0.58%
53,838
IBB icon
61
iShares Biotechnology ETF
IBB
$9.46B
$1.9M 0.55%
14,616
+630
+5% +$82.1K
MGA icon
62
Magna International
MGA
$19.1B
$1.84M 0.53%
28,650
+7,815
+38% +$579K
JNJ icon
63
Johnson & Johnson
JNJ
$619B
$1.73M 0.5%
9,773
+200
+2% +$34K
GOOG icon
64
Alphabet (Google) Class C
GOOG
$4.62T
$1.65M 0.48%
11,780
-1,080
-8% -$147K
CVX icon
65
Chevron
CVX
$373B
$1.48M 0.43%
9,063
+100
+1% +$14.3K
LLY icon
66
Eli Lilly
LLY
$1.02T
$1.28M 0.37%
4,473
PFE icon
67
Pfizer
PFE
$145B
$1.23M 0.36%
23,832
VEU icon
68
Vanguard FTSE All-World ex-US ETF
VEU
$68.2B
$1.19M 0.34%
20,579
SYK icon
69
Stryker
SYK
$127B
$1.16M 0.34%
4,354
PAYX icon
70
Paychex
PAYX
$41.5B
$1.05M 0.3%
7,675
ORCL icon
71
Oracle
ORCL
$417B
$844K 0.25%
10,211
CAT icon
72
Caterpillar
CAT
$411B
$789K 0.23%
3,542
MMM icon
73
3M
MMM
$94B
$751K 0.22%
6,040
-209
-3% -$27.8K
DHR icon
74
Danaher
DHR
$139B
$671K 0.19%
2,581
SYY icon
75
Sysco
SYY
$40.3B
$668K 0.19%
8,190

Similar funds

Boston Research & Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boston Research & Management held 117 positions worth $344M, down 5.9% from $366M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q1 2022 filing shows 5 new, 25 increased, 42 reduced and 6 closed positions. Its largest new stake was Invesco QQQ Trust: 1,170 shares worth $424K. The largest sale was Accenture, an estimated $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management's largest Q1 2022 buy was Invesco QQQ Trust: 1,170 shares worth $424K.
  • Boston Research & Management added most to JPMorgan Chase in Q1 2022, an estimated $1.19M increase.
  • Boston Research & Management's biggest Q1 2022 reduction was Accenture, cutting an estimated $2.3M.
  • Boston Research & Management fully exited AT&T in Q1 2022, selling an estimated $344K.
  • Boston Research & Management's ten largest holdings make up 28% of its $344M portfolio in Q1 2022.
  • Boston Research & Management opened 5 new positions and closed 6 in Q1 2022.
  • Boston Research & Management's portfolio value fell 5.9% quarter-over-quarter to $344M.

Based on Boston Research & Management's 13F filing for Q1 2022, filed 12 May 2022.